THERAPEUTIC EFFECTS OF CEFOXITIN IN THE TREATMENT OF VARIOUS INFECTIONS OF CHILDREN

In order to ascertain the therapeutic effects of cefoxitin (CFX), a new semisynthetic cephamycin antibiotic, it was administered to pediatric patients with several infections. There were 8 patients with acute respiratory disease (ARD), 3 with urinary tract infection (UTI), 2 with appendicitis compli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Japanese journal of antibiotics 1981/03/25, Vol.34(3), pp.374-383
Hauptverfasser: WAKIGUCHI, HIROSHI, OZAKI, HIROSHI, NISHIBAYASHI, YOHEI, HAMAWAKI, MITSUNORI, KURASHIGE, TAKANOBU, KITAMURA, ISAMU
Format: Artikel
Sprache:jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In order to ascertain the therapeutic effects of cefoxitin (CFX), a new semisynthetic cephamycin antibiotic, it was administered to pediatric patients with several infections. There were 8 patients with acute respiratory disease (ARD), 3 with urinary tract infection (UTI), 2 with appendicitis complicated with peritonitis, 2 with scarlet fever, one each of left coxitis, infected medial cervical cyst, febrile illness after a V-P shunt operation, purulent parotitis and intractable diarrhea with fever, namely, a total of 20 patients aged from one month to 11 years 6 months. A CFX vial which contained 1 g of CFX was used in two ways, i. e., one shot intravenos injection and drip infusion. The dosage of the drug varied from 57 to 121 mg/kg/day and the administration was continued from 2 to 20 days. Clinical effects were evaluated as follows: when cardinal symptoms disapperared within 3 days it was considered to be ‘excellent’ ; within 5 days ‘good’ and no change of clinical symptoms within 5 days ‘poor’. The bacteriologicalcal effect was expressed as ‘eliminated’, ‘unchanged’ and ‘undetermined’. Clinical efficacy evaluated as ‘excellent’ occured in 11 cases, ‘good’ in 8 cases and ‘poor’ in 1 case, the efficacy rate being 95.0% When classified by the disease, the efficacy rate was as follows: ‘good’ to ‘excellent’ in 7 out of the 8 cases of ARD, ‘excellent’ in all of the 3 cases of UTI, ‘good’ and ‘excellent’ in the 2 cases of scarlet fever and in the 2 cases of peritonitis, ‘excellent’ ineachcase of left coxitis, purulent parotitis and intractable diarrhea with fever, ‘good’ in each case of infected medial cervical cyst and febrile illness after a V-P shunt operation. From the bacteriological point of view, ‘eliminated’ occured in 5 cases, ‘reduced’ in 1 case and ‘undetermined’ in the 2 cases of ARD, ‘eliminated’ in all of the 3 cases of UTI, ‘eliminated’ in 1 case and ‘undetermined’ in the 1 case of peritonitis, ‘undetermined’ in the 2 cases of scarlet fever, ‘eliminated’ in each case of infected medial cervical cyst and purulent parotitis and ‘undetermined’ in the other cases. Antimicrobial efficacy measured by MIC was compared with CEZ and CET, and the results were as follows: CFX was inferior to the two cephalosporins for S. aureus, it was between CEZ and CET for H. influenzae and H. parainfluenzae, and CFX was superior to CEZ and CET for E. coli All of the 3 antibiotics had poor antimicrobial efficacy for P. aeruginosa and S. faecalis. There were neither cl
ISSN:0368-2781
2186-5477
DOI:10.11553/antibiotics1968b.34.374